We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

AC:EURONEXT PARISAccor SA Analysis

Data as of 2026-06-22 - not real-time

$127.98

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Accenture plc is trading at $127.98, which is dramatically below its DCF‑derived fair value of $334.67, implying roughly a 54% upside potential. The stock’s price‑to‑earnings multiple of 10.2 is well under the industry average of 38.1, underscoring a deep valuation gap. A dividend yield of 5.09% with a payout ratio just above 50% is supported by robust free cash flow of $12.1 bn and a solid cash‑to‑debt ratio. Technical indicators show the shares are in oversold territory (RSI 20.9) and below all major moving averages (20‑day SMA $173.2, 50‑day SMA $177.8, 200‑day SMA $226.1), with the MACD line remaining bearish (-7.57) and a support level near $125.6. Volatility is elevated at 74% over the past 30 days, though beta is modest at 0.57, suggesting market‑wide swings rather than company‑specific risk.
Strategically, Accenture’s collaborations with AI leaders such as OpenAI, Microsoft, and AWS position it to capture growth in high‑margin digital transformation services, while its diversified global footprint and strong operating cash flow provide resilience. The combination of a substantial valuation upside, attractive dividend, and strategic growth levers makes the stock a compelling value‑oriented buy across horizons.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • RSI indicates oversold conditions
  • Proximity to support level at $125.6
  • High dividend yield provides immediate income

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Large valuation gap versus DCF fair value
  • Strong free cash flow and low debt-to-equity
  • Strategic AI partnerships driving future growth

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Sustainable dividend supported by cash generation
  • Robust client base across multiple geographies
  • Continued exposure to high‑margin digital and cloud services

Key Metrics & Analysis

Financial Health

Revenue Growth5.60%
Profit Margin10.66%
P/E Ratio10.2
ROE24.41%
ROA10.90%
Debt/Equity25.04
P/B Ratio2.5
Op. Cash Flow$13.2B
Free Cash Flow$12.1B
Industry P/E38.1

Technical Analysis

TrendBearish
RSI20.9
Support$125.60
Resistance$198.00
MA 20$173.22
MA 50$177.80
MA 200$226.11
MACDBearish
VolumeIncreasing
Fear & Greed Index90.27

Valuation

Fair Value$334.67
Target Price$197.65
Upside/Downside54.44%
GradeUndervalued
TypeValue
Dividend Yield5.09%

Risk Assessment

Beta0.57
Volatility74.37%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.